The human prion protein fragment PrP106-126 is a highly fibrillogenic peptide, resistant to proteinases and toxic to neurons; it derives from the normal prion protein (PrPC), with which it can interact, thus inhibiting its superoxide dismutase-like activity. The same properties are also shown by the abnormal isoform of the prion protein (PrPSc), and this similarity makes PrP106-126 an interesting model for the neurotoxic action of PrPSc. A role for copper in PrP106-126 aggregation and toxicity has recently been evidenced, and the interaction of terminal Lys, His and Met residues with the copper ion at neutral pH has been suggested. In order to shed more light on the the complex-formation equilibria of PrP106-126 with the copper ion, a thor...
The prion protein (PrP) is a cell-surface protein which has the potential to cause mammalian neurode...
The cellular prion protein (PrPC) is a Cu2+ binding protein connected to the outer cell membrane. Th...
Complex formation processes between the 39-mer residue peptide fragment of human prion protein, HuPr...
The human prion protein fragment PrP106-126 is a highly fibrillogenic peptide, resistant to protein...
Copper(II) complexes of the neurotoxic peptide fragments of human and chicken prion proteins were st...
Copper(II) complexes of the neurotoxic peptide fragments of human and chicken prion proteins were st...
Among the common features shared by neurodegenerative diseases there is the central role played by s...
Transmissible spongiform encephalopathies (TSEs) in mammals are neurodegenerative diseases caused by...
Prion diseases are neurodegenerative disorders associated with a conformational change of the normal...
In this paper, we report the characterization of copper(II) complexes with two prion (PrP) protein p...
The synthetic peptide encompassing residues 106-126 (PrP106-126, KTNMKHMAGAAAA-GAVVGGLG) of the huma...
The synthetic peptide encompassing residues 106-126 (PrP106-126, KTNMKHMAGAAAA-GAVVGGLG) of the huma...
Many systemic and neurodegenerative disorders, collectively termed as “protein conformational diseas...
Combined potentiometric, calorimetric and spectroscopic methods were used to investigate the Cu2+ bi...
Combined potentiometric, calorimetric and spectroscopic methods were used to investigate the Cu2+ bi...
The prion protein (PrP) is a cell-surface protein which has the potential to cause mammalian neurode...
The cellular prion protein (PrPC) is a Cu2+ binding protein connected to the outer cell membrane. Th...
Complex formation processes between the 39-mer residue peptide fragment of human prion protein, HuPr...
The human prion protein fragment PrP106-126 is a highly fibrillogenic peptide, resistant to protein...
Copper(II) complexes of the neurotoxic peptide fragments of human and chicken prion proteins were st...
Copper(II) complexes of the neurotoxic peptide fragments of human and chicken prion proteins were st...
Among the common features shared by neurodegenerative diseases there is the central role played by s...
Transmissible spongiform encephalopathies (TSEs) in mammals are neurodegenerative diseases caused by...
Prion diseases are neurodegenerative disorders associated with a conformational change of the normal...
In this paper, we report the characterization of copper(II) complexes with two prion (PrP) protein p...
The synthetic peptide encompassing residues 106-126 (PrP106-126, KTNMKHMAGAAAA-GAVVGGLG) of the huma...
The synthetic peptide encompassing residues 106-126 (PrP106-126, KTNMKHMAGAAAA-GAVVGGLG) of the huma...
Many systemic and neurodegenerative disorders, collectively termed as “protein conformational diseas...
Combined potentiometric, calorimetric and spectroscopic methods were used to investigate the Cu2+ bi...
Combined potentiometric, calorimetric and spectroscopic methods were used to investigate the Cu2+ bi...
The prion protein (PrP) is a cell-surface protein which has the potential to cause mammalian neurode...
The cellular prion protein (PrPC) is a Cu2+ binding protein connected to the outer cell membrane. Th...
Complex formation processes between the 39-mer residue peptide fragment of human prion protein, HuPr...